1h Free Analyst Time
The China in-vitro diagnostics market is poised to grow by $6.93 billion during 2020-2024 progressing at a CAGR of 17% during the forecast period. Our reports on China in-vitro diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current china market scenario, latest trends and drivers, and the overall market environment.Speak directly to the analyst to clarify any post sales queries you may have.
The market is driven by the increase in incidences of chronic and infectious diseases, geriatric population in China and increase in adoption of POC testing. In addition, increase in incidences of chronic and infectious diseases is anticipated to boost the growth of the market as well.
The China in-vitro diagnostics market analysis includes the end-user segment and geographical landscapes.
The China in-vitro diagnostics market is segmented as below:
By End-user
- Hospitals
- Homecare
- Research Institutes
- Independent Laboratories
By Application
- Immunochemistry
- Tissue Diagnostics
- Molecular Diagnostics
- Hematology
- Others
This study identifies the healthcare infrastructure expansion as one of the prime reasons driving the China in-vitro diagnostics market growth during the next few years. Also, continuous advances in IVD procedures and companion diagnostics will lead to sizable demand in the market.
The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our China in-vitro diagnostics market covers the following areas:
- China in-vitro diagnostics market sizing
- China in-vitro diagnostics market forecast
- China in-vitro diagnostics market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading China in-vitro diagnostics market vendors that include Abbott Laboratories, Agilent Technologies Inc., Autobio Diagnostics Co. Ltd., Bioptik Technology Inc., Bio-Rad Laboratories Inc., Danaher Corp., F. Hoffmann-La Roche Ltd., Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Siemens Healthineers AG, and Sysmex Corp. Also, the China in-vitro diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary.
The analyst's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
Table of Contents
Executive Summary
Market Landscape
Market Sizing
Five Forces Analysis
Market Segmentation by Application
Market Segmentation by End-user
Customer Landscape
Vendor Landscape
Vendor Analysis
Appendix
List of Exhibits
Executive Summary
The analyst recognizes the following companies as the key players in the China in-vitro diagnostics market: Abbott Laboratories, Agilent Technologies Inc., Autobio Diagnostics Co. Ltd., Bioptik Technology Inc., Bio-Rad Laboratories Inc., Danaher Corp., F. Hoffmann-La Roche Ltd., Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Siemens Healthineers AG, and Sysmex Corp..According to one of the team's analysts: The latest trend gaining momentum in the market is geriatric population in China.
According to the report, one of the major drivers for this market is the increase in incidences of chronic and infectious diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Agilent Technologies Inc.
- Autobio Diagnostics Co. Ltd.
- Bioptik Technology Inc.
- Bio-Rad Laboratories Inc.
- Danaher Corp.
- F. Hoffmann-La Roche Ltd.
- Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
- Siemens Health
